Use of inhibitors of scinderin and/or ephrin-A1 for treating tumors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 15, 2011
Grant Date -
Jun 18, 2009
app pub date -
Dec 28, 2006
filing date -
Dec 30, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to the use of inhibitors of the expression or the activity of scinderin and/or of ephrin-A1 inhibitors for increasing the susceptibility of tumor cells to CTL killing. Such inhibitors may be for instance interfering RNAs targeting the scinderin gene and/or interfering RNAs targeting the ephrin-A1 gene.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully